Literature DB >> 3127398

Chain-fluorinated polyamines as tumor markers. II. Metabolic aspects in normal tissues.

N Seiler1, S Sarhan, B Knödgen, F Gerhart.   

Abstract

The objective of this work was to study certain metabolic aspects of fluorine-substituted analogues of natural polyamines in healthy experimental animals, with the aim of exploring their potential application as tumor markers. Tissue polyamine concentrations were more effectively depleted by combined treatment with D,L-alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, and N1,N4-bis-allenylputrescine, an inactivator of polyamine oxidase, than with either inhibitor alone. This suggests the general importance of polyamine interconversion as a metabolic source of putrescine. Administration of 2,2-difluoroputrescine after 2 weeks pretreatment with the two inhibitors caused the formation of 6,6-difluorospermidine and 6,6-difluorospermidine in nearly all tissues. Highest concentrations of the chain-fluorinated polyamines were observed in the small intestine. At 24 h after 2,2-difluoroputrescine administration the amount was about 8% of the normal endogenous polyamine pool in the small intestine, but lower in all other tissues. Replenishment of endogenous polyamine pools is a relatively slow process. Approximately 9 days after cessation of treatment with the two inhibitors normal values had been reestablished. The rate of formation of endogenous polyamines was not affected by the presence of their difluoro analogues. Elimination of the chain-fluorinated polyamines from tissues seems not to follow normal polyamine metabolic patterns. Their most rapid elimination coincides with the enhancement of endogenous polyamines, indicating that the fluoro analogues are displaced by the natural polyamines. Most of the 2,2-difluoroputrescine was rapidly excreted in the urine, and formation of a conjugate was detected. 6,6-Difluorospermidine was also a urinary excretion product. However, the metabolic fate of 6,6-difluorospermine could not be clarified. It was not found in urine, either free or as conjugate. The relatively low accumulation of chain-fluorinated polyamines, together with their rapid elimination from normal tissues are characteristics which together with their previously established selective uptake into rapidly proliferating tissues recommend them as potential tumor markers that can be determined by 19F-NMR spectroscopy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3127398     DOI: 10.1007/bf00390488

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  11 in total

1.  The role of polyamine reutilization in depletion of cellular stores of polyamines in non-proliferating tissues.

Authors:  F N Bolkenius; N Seiler
Journal:  Biochim Biophys Acta       Date:  1987-01-20

2.  Replacement of natural polyamines by cadaverine and its aminopropyl derivatives in Ehrlich ascites carcinoma cells.

Authors:  L Alhonen-Hongisto; P Seppänen; E Hölttä; J Jänne
Journal:  Biochem Biophys Res Commun       Date:  1982-05-31       Impact factor: 3.575

3.  The influence of catabolic reactions on polyamine excretion.

Authors:  N Seiler; F N Bolkenius; B Knödgen
Journal:  Biochem J       Date:  1985-01-01       Impact factor: 3.857

4.  Putrescine catabolism in mammalian brain.

Authors:  N Seiler; M J Al-Therib
Journal:  Biochem J       Date:  1974-10       Impact factor: 3.857

5.  On the turnover of polyamines spermidine and spermine in mouse brain and other organs.

Authors:  H Antrup; N Seiler
Journal:  Neurochem Res       Date:  1980-02       Impact factor: 3.996

6.  Ornithine decarboxylase inhibitors increase the cellular content of the enzyme: implications for translational regulation.

Authors:  L Persson; S M Oredsson; S Anehus; O Heby
Journal:  Biochem Biophys Res Commun       Date:  1985-08-30       Impact factor: 3.575

7.  Accumulation of decarboxylated S-adenosyl-L-methionine in mammalian cells as a consequence of the inhibition of putrescine biosynthesis.

Authors:  P S Mamont; C Danzin; J Wagner; M Siat; A M Joder-Ohlenbusch; N Claverie
Journal:  Eur J Biochem       Date:  1982-04

8.  Tumor selective enhancement of radioactivity uptake in mice treated with alpha-difluoromethylornithine prior to administration of 14C-putrescine.

Authors:  J E Chaney; K Kobayashi; R Goto; G A Digenis
Journal:  Life Sci       Date:  1983-03-14       Impact factor: 5.037

9.  Specific inhibition of polyamine oxidase in vivo is a method for the elucidation of its physiological role.

Authors:  F N Bolkenius; P Bey; N Seiler
Journal:  Biochim Biophys Acta       Date:  1985-01-28

10.  Chain-fluorinated polyamines as tumor markers--I. In vivo transformation of 2,2-difluoroputrescine into 6,6-difluorospermidine and 6,6-difluorospermine.

Authors:  S Sarhan; B Knodgen; F Gerhart; N Seiler
Journal:  Int J Biochem       Date:  1987
View more
  1 in total

Review 1.  Current status of the polyamine research field.

Authors:  Anthony E Pegg; Robert A Casero
Journal:  Methods Mol Biol       Date:  2011
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.